Acumen Pharmaceuticals, Inc.
ABOSNASDAQHealthcareBiotechnology
As of Oct 22, 2026 close
- Market cap
- $148.84M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.50$3.60
- Volume (live)
- -
- Avg. volume (3M)
- 565.38K
Acumen Pharmaceuticals (ABOS) Stock Price & Financial Analysis
Acumen Pharmaceuticals Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.01 - $2.14 |
|---|---|
| 52-Week High | $3.60 |
| 52-Week Low | $1.50 |
| Open | $2.03 |
| Volume (last close) | 569.42K |
| Average Volume (3M) | 565.38K |
| 50-Day MA | $2.54 |
|---|---|
| 200-Day MA | $2.50 |
| 1-Year Change | −2.37% |
| Market Cap | 148.84M |
|---|---|
| Shares Outstanding | 72.25M |
| Price to Book (P/B) | 2.60 |
| EV/EBITDA | -1.20 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Acumen Pharmaceuticals at a Glance
As of the Oct 22, 2026 close, Acumen Pharmaceuticals (ABOS) has a market capitalization of $148.84M.
As of its latest reported balance sheet, it holds $59.44M in cash and securities against $31.57M of debt, a net cash position of $27.87M.
Acumen Pharmaceuticals does not currently pay a dividend.
The share price is down 2.4% over the past year. At $2.06 (the Oct 22, 2026 close) it sits within its 52-week range of $1.50 to $3.60, below its 200-day moving average of $2.50.
Frequently Asked Questions About Acumen Pharmaceuticals
What is the current stock price for ABOS?
As of the Oct 22, 2026 close, ABOS stock trades at $2.06. The 52-week range is $1.50–$3.60, with a day range of $2.01–$2.14.
What is the P/E ratio for ABOS?
The P/E ratio (Price-to-Earnings) for ABOS is shown in the Key Statistics section. This valuation metric helps compare Acumen Pharmaceuticals, Inc. to industry peers.
Does ABOS pay dividends?
Acumen Pharmaceuticals does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ABOS?
Analyst ratings and recommendations for ABOS are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of ABOS?
As of the Oct 22, 2026 close, Acumen Pharmaceuticals's market capitalization is $148.8M, classifying it as a micro-cap company. Acumen Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.